Author:
Barton Kenneth N.,Paielli Dell,Zhang Yingshu,Koul Sweaty,Brown Stephen L.,Lu Mei,Seely John,Ho Kim Jae,Freytag Svend O.
Subject
Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine
Reference33 articles.
1. A phase I study of ONYX-015, an E1B attenuated adenovirus, administered intratumorally to subjects with recurrent head and neck cancer;Ganly;Clin. Cancer Res,2000
2. Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in subjects with refractory head and neck cancer;Nemunaitis;J. Clin. Oncol,2001
3. Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in subjects with advanced head and neck cancer: a phase II trial;Nemunaitis;Cancer Res,2000
4. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in subjects with recurrent head and neck cancer;Khuri;Nat. Med,2000
5. A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma;Hecht;Clin. Cancer Res,2003
Cited by
81 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献